Paul Bird

5.4k total citations
22 papers, 297 citations indexed

About

Paul Bird is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Paul Bird has authored 22 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 6 papers in Epidemiology and 5 papers in Molecular Biology. Recurrent topics in Paul Bird's work include SARS-CoV-2 and COVID-19 Research (8 papers), SARS-CoV-2 detection and testing (8 papers) and COVID-19 Clinical Research Studies (7 papers). Paul Bird is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (8 papers), SARS-CoV-2 detection and testing (8 papers) and COVID-19 Clinical Research Studies (7 papers). Paul Bird collaborates with scholars based in United Kingdom, Australia and Singapore. Paul Bird's co-authors include Julian W. Tang, Srini Bandi, Raymond U. Lemieux, Ole Hindsgaul, Christopher W. Holmes, André Venot, Naohiko Morishima, David R. Bundle, Ulrike Spohr and Zoha Mohammad and has published in prestigious journals such as PLoS ONE, Kidney International and The Journal of Infectious Diseases.

In The Last Decade

Paul Bird

19 papers receiving 286 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Bird United Kingdom 8 171 59 56 46 44 22 297
Daniela E. Kirwan United Kingdom 12 294 1.7× 22 0.4× 81 1.4× 98 2.1× 14 0.3× 26 489
Helen Kest United States 9 110 0.6× 16 0.3× 54 1.0× 50 1.1× 22 0.5× 21 261
Liyuan Zhang China 10 269 1.6× 23 0.4× 60 1.1× 21 0.5× 40 0.9× 25 484
Federica Di Timoteo Italy 5 164 1.0× 14 0.2× 73 1.3× 50 1.1× 12 0.3× 6 314
Hitoshi Kawasuji Japan 10 304 1.8× 17 0.3× 37 0.7× 16 0.3× 12 0.3× 42 379
Derek L.L. Hung Hong Kong 6 173 1.0× 33 0.6× 43 0.8× 12 0.3× 9 0.2× 11 323
Kartik Kumar United Kingdom 11 204 1.2× 72 1.2× 139 2.5× 34 0.7× 3 0.1× 41 582
Renan Marrichi Mauch Brazil 11 67 0.4× 129 2.2× 75 1.3× 12 0.3× 6 0.1× 23 318
Robbert G. Bentvelsen Netherlands 7 375 2.2× 74 1.3× 21 0.4× 13 0.3× 14 0.3× 17 510
Katherine Fenstermacher United States 11 104 0.6× 14 0.2× 53 0.9× 37 0.8× 9 0.2× 30 297

Countries citing papers authored by Paul Bird

Since Specialization
Citations

This map shows the geographic impact of Paul Bird's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Bird with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Bird more than expected).

Fields of papers citing papers by Paul Bird

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Bird. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Bird. The network helps show where Paul Bird may publish in the future.

Co-authorship network of co-authors of Paul Bird

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Bird. A scholar is included among the top collaborators of Paul Bird based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Bird. Paul Bird is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khan, Tauseef, Umakhanth Venkatraman Girija, Randolph Arroo, et al.. (2025). Complement evasion strategies of Candida glabrata clinical isolates and antibody independent binding of C1q to C. glabrata. Immunobiology. 230(4). 152923–152923.
2.
Gogoi, Mayuri, Christopher Martin, Paul Bird, et al.. (2024). Risk of vaccine preventable diseases in UK migrants: A serosurvey and concordance analysis. Journal of Migration and Health. 9. 100217–100217. 3 indexed citations
3.
Pan, Daniel, Mayuri Gogoi, Amani Al‐Oraibi, et al.. (2024). Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis – update from 2017 to 2023. EClinicalMedicine. 75. 102801–102801. 5 indexed citations
4.
Tang, Julian W., Meik Dilcher, Paul Bird, et al.. (2023). Practical problems and responses for SARS-CoV-2 laboratory testing during the COVID-19 pandemic. Clinical Microbiology and Infection. 29(5). 560–562. 2 indexed citations
5.
Nazareth, Joshua, Daniel Pan, Jee Whang Kim, et al.. (2022). Discriminatory Ability of Gas Chromatography–Ion Mobility Spectrometry to Identify Patients Hospitalized With COVID-19 and Predict Prognosis. Open Forum Infectious Diseases. 9(11). ofac509–ofac509. 7 indexed citations
6.
Allsopp, Rebecca C., Caroline Cowley, Ruth Barber, et al.. (2022). A rapid RT-LAMP SARS-CoV-2 screening assay for collapsing asymptomatic COVID-19 transmission. PLoS ONE. 17(9). e0273912–e0273912. 5 indexed citations
8.
Bird, Paul, Jessica Shaw, Mina Odedra, et al.. (2022). Prospective Surveillance of Respiratory Infections in British Antarctic Survey Bases During the COVID-19 Pandemic. The Journal of Infectious Diseases. 226(12). 2105–2112.
9.
10.
Billany, Roseanne E, Haresh Selvaskandan, Sherna Adenwalla, et al.. (2021). Seroprevalence of antibody to S1 spike protein following vaccination against COVID-19 in patients receiving hemodialysis: a call to arms. Kidney International. 99(6). 1492–1494. 45 indexed citations
11.
Bird, Paul, et al.. (2021). Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) seroconversion in hematology–oncology patients. Journal of Medical Virology. 93(7). 4585–4591. 9 indexed citations
12.
Williams, Caroline, Daniel Pan, Shirley Sze, et al.. (2021). Exhaled SARS-CoV-2 quantified by face-mask sampling in hospitalised patients with COVID-19. Journal of Infection. 82(6). 253–259. 30 indexed citations
13.
Morris, Thomas, et al.. (2021). Xpert Xpress Flu/RSV: Validation and impact evaluation at a large UK hospital trust. Journal of Medical Virology. 93(8). 5146–5151. 4 indexed citations
14.
Pan, Daniel, Shirley Sze, Benedict Rogers, et al.. (2020). Serial simultaneously self-swabbed samples from multiple sites show similarly decreasing SARS-CoV-2 loads in COVID-19 cases of differing clinical severity. Journal of Infection. 81(6). 979–997. 4 indexed citations
15.
Bandi, Srini, et al.. (2020). COVID‐19 multisystem inflammatory syndrome in three teenagers with confirmed SARS‐CoV‐2 infection. Journal of Medical Virology. 92(11). 2880–2886. 38 indexed citations
16.
Bandi, Srini, et al.. (2020). COVID-19 in Neonates and Infants: Progression and Recovery. The Pediatric Infectious Disease Journal. 39(7). e140–e142. 24 indexed citations
17.
Hale, G, Eleanor Berrie, & Paul Bird. (2004). Design and manufacture of monoclonal antibodies for radioimmunotherapy.. PubMed. 48(4). 258–66. 3 indexed citations
18.
Lemieux, Raymond U., et al.. (1988). The binding of the Lewis-a human blood group determinant by two hybridoma monoclonal anti-Lea antibodies. Carbohydrate Research. 178(1). 293–305. 16 indexed citations
19.
Lemieux, Raymond U., André Venot, Ulrike Spohr, et al.. (1985). Molecular recognition. V. The binding of the B human blood group determinant by hybridoma monoclonal antibodies. Canadian Journal of Chemistry. 63(10). 2664–2668. 36 indexed citations
20.
Bird, Paul, et al.. (1984). An automatic monitoring system for measuring handwashing frequency in hospital wards. Journal of Hospital Infection. 5(4). 447–453. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026